Home > Publications Database > Neuronal extracellular vesicles and associated microRNAs induce circuit connectivity downstream BDNF. > print |
001 | 256467 | ||
005 | 20240826165950.0 | ||
024 | 7 | _ | |a 10.1016/j.celrep.2023.112063 |2 doi |
024 | 7 | _ | |a pmid:36753414 |2 pmid |
024 | 7 | _ | |a 2211-1247 |2 ISSN |
024 | 7 | _ | |a 2639-1856 |2 ISSN |
024 | 7 | _ | |a altmetric:142262957 |2 altmetric |
037 | _ | _ | |a DZNE-2023-00329 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Antoniou, Anna |0 P:(DE-2719)2812905 |b 0 |e First author |u dzne |
245 | _ | _ | |a Neuronal extracellular vesicles and associated microRNAs induce circuit connectivity downstream BDNF. |
260 | _ | _ | |a [New York, NY] |c 2023 |b Elsevier |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1718181743_28346 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a CC BY |
520 | _ | _ | |a Extracellular vesicles (EVs) have emerged as mediators of cellular communication, in part via the delivery of associated microRNAs (miRNAs), small non-coding RNAs that regulate gene expression. We show that brain-derived neurotrophic factor (BDNF) mediates the sorting of miR-132-5p, miR-218-5p, and miR-690 in neuron-derived EVs. BDNF-induced EVs in turn increase excitatory synapse formation in recipient hippocampal neurons, which is dependent on the inter-neuronal delivery of these miRNAs. Transcriptomic analysis further indicates the differential expression of developmental and synaptogenesis-related genes by BDNF-induced EVs, many of which are predicted targets of miR-132-5p, miR-218-5p, and miR-690. Furthermore, BDNF-induced EVs up-regulate synaptic vesicle (SV) clustering in a transmissible manner, thereby increasing synaptic transmission and synchronous neuronal activity. As BDNF and EV-miRNAs miR-218 and miR-132 were previously implicated in neuropsychiatric disorders such as anxiety and depression, our results contribute to a better understanding of disorders characterized by aberrant neural circuit connectivity. |
536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 1 |
536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 2 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a MicroRNAs |2 NLM Chemicals |
650 | _ | 7 | |a BDNF |2 Other |
650 | _ | 7 | |a CP: Neuroscience |2 Other |
650 | _ | 7 | |a exosome |2 Other |
650 | _ | 7 | |a extracellular vesicle |2 Other |
650 | _ | 7 | |a microRNA |2 Other |
650 | _ | 7 | |a network connectivity |2 Other |
650 | _ | 7 | |a neural circuit |2 Other |
650 | _ | 7 | |a synapse |2 Other |
650 | _ | 7 | |a synapse clustering |2 Other |
650 | _ | 7 | |a Brain-Derived Neurotrophic Factor |2 NLM Chemicals |
650 | _ | 2 | |a MicroRNAs: genetics |2 MeSH |
650 | _ | 2 | |a MicroRNAs: metabolism |2 MeSH |
650 | _ | 2 | |a Brain-Derived Neurotrophic Factor: metabolism |2 MeSH |
650 | _ | 2 | |a Neurons: metabolism |2 MeSH |
650 | _ | 2 | |a Extracellular Vesicles: metabolism |2 MeSH |
700 | 1 | _ | |a Auderset, Loic |0 P:(DE-2719)9001301 |b 1 |u dzne |
700 | 1 | _ | |a Kaurani, Lalit |0 P:(DE-2719)2812832 |b 2 |u dzne |
700 | 1 | _ | |a Sebastian, Eva |0 P:(DE-2719)9002055 |b 3 |u dzne |
700 | 1 | _ | |a Zeng, Yuzhou |0 P:(DE-2719)9001925 |b 4 |u dzne |
700 | 1 | _ | |a Allahham, Maria |b 5 |
700 | 1 | _ | |a Cases-Cunillera, Silvia |b 6 |
700 | 1 | _ | |a Schoch, Susanne |b 7 |
700 | 1 | _ | |a Gründemann, Jan |0 P:(DE-2719)9001219 |b 8 |u dzne |
700 | 1 | _ | |a Fischer, Andre |0 P:(DE-2719)2000047 |b 9 |u dzne |
700 | 1 | _ | |a Schneider, Anja |0 P:(DE-2719)2812035 |b 10 |e Last author |u dzne |
773 | _ | _ | |a 10.1016/j.celrep.2023.112063 |g Vol. 42, no. 2, p. 112063 - |0 PERI:(DE-600)2649101-1 |n 2 |p 112063 |t Cell reports |v 42 |y 2023 |x 2211-1247 |
856 | 4 | _ | |u https://pub.dzne.de/record/256467/files/DZNE-2023-00329.pdf |y OpenAccess |
856 | 4 | _ | |u https://pub.dzne.de/record/256467/files/DZNE-2023-00329.pdf?subformat=pdfa |x pdfa |y OpenAccess |
909 | C | O | |o oai:pub.dzne.de:256467 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2812905 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)9001301 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2812832 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)9002055 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)9001925 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)9001219 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2000047 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2812035 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 1 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 2 |
914 | 1 | _ | |y 2023 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-17 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-17 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2022-11-17 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T08:49:39Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T08:49:39Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-05-02T08:49:39Z |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL REP : 2022 |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-26 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL REP : 2022 |d 2023-10-26 |
920 | 1 | _ | |0 I:(DE-2719)1011305 |k AG Schneider |l Translational Dementia Research (Bonn) |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1410002 |k AG Fischer |l Epigenetics and Systems Medicine in Neurodegenerative Diseases |x 1 |
920 | 1 | _ | |0 I:(DE-2719)5000069 |k AG Gründemann |l Neural Circuit Computations |x 2 |
920 | 1 | _ | |0 I:(DE-2719)1013002 |k AG Bradke |l Axon Growth and Regeneration |x 3 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1011305 |
980 | _ | _ | |a I:(DE-2719)1410002 |
980 | _ | _ | |a I:(DE-2719)5000069 |
980 | _ | _ | |a I:(DE-2719)1013002 |
980 | _ | _ | |a UNRESTRICTED |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|